The NDA formalizes Advent's access to non-public information, indicating the Special Committee is engaging in earnest. The standstill prevents Advent from launching a hostile bid or increasing its stake without consent, but the explicit carve-out for continued discussions with the Special Committee and Krantz suggests a negotiated deal is the likely path. Watch for a definitive agreement announcement or a competing bid from a third party, which would trigger the standstill's Fall-Away Event and potentially escalate the process.
Price Chart
Executive Summary
Advent International filed Amendment No. 1 to its Schedule 13D, disclosing entry into a confidentiality agreement (NDA) with Definitive Healthcare Corp. on September 29, 2026. The NDA includes a 12-month standstill and non-solicitation provisions, but explicitly permits Advent to continue engaging with the Special Committee and founder Jason Krantz regarding a potential acquisition. Advent's beneficial ownership remains unchanged at 58.54% (62,493,676 shares), and no transactions were effected since the original filing. This formalizes the process around Advent's September 1 non-binding $1.02/share offer (36% premium to 60-day VWAP), signaling the go-private process is advancing into due diligence.
Key Financial Metrics
Key Facts
- Advent International entered into a confidentiality agreement with Definitive Healthcare on September 29, 2026, to facilitate due diligence for a potential acquisition.
- Advent's beneficial ownership remains at 58.54% (62,493,676 shares of Class A Common Stock), unchanged since the original Schedule 13D filed September 2, 2026.
- The NDA includes a 12-month standstill provision barring Advent from acquiring additional securities, seeking board representation, or launching a tender offer without the Company's consent, subject to exceptions including discussions with Jason Krantz and the Special Committee.
- The standstill terminates upon a 'Fall-Away Event' such as the Company entering a definitive agreement with a third party, a third-party tender offer, or a change in board composition.
- Advent's September 1, 2026 non-binding proposal offered $1.02 per share in cash, a 36% premium to the 60-day VWAP of $0.75, and is not subject to a financing condition.
- The NDA explicitly permits Advent to continue engaging with the Special Committee and Jason Krantz regarding a transaction.
- No transactions in Common Stock were effected by Advent since the original Schedule 13D filing.
Financial Impact
Advent's $1.02/share all-cash offer represents a 36% premium to the 60-day VWAP of $0.75. Based on 106,744,713 shares outstanding, the implied equity value is approximately $108.9 million.
Risk Factors
- The $1.02/share offer may be rejected by the Special Committee as inadequate, leading to a stalemate or Advent walking away.
- The 12-month standstill limits Advent's ability to apply public pressure or launch a tender offer without the Company's consent, potentially slowing the timeline.
- Advent's 58.54% stake means any transaction requires careful handling of related-party and minority shareholder considerations.
- The non-binding nature of the proposal means Advent could withdraw or modify terms at any time.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001140361-26-038313 |
| Document: 0001140361-26-038313-index-headers.html | 0001140361-26-038313 |
| Document: 0001140361-26-038313-index.html | 0001140361-26-038313 |
| Document: 0001140361-26-038313.txt | 0001140361-26-038313 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | SC 13D/A | $0.9333 $0.9800 | ▲ +5.00% | ▲ +3.84% | $1.11 (+18.40%) |
Sep 9, 2026 6w ago | 8-K | $1.03 $0.9650 | ▼ −6.31% | ▼ −5.22% | $1.11 (+7.28%) |
Sep 2, 2026 7w ago | 8-K | $1.04 $1.03 | ▼ −0.96% | ▼ −0.00% | $1.11 (+6.25%) |
Sep 2, 2026 7w ago | Press Release | $1.04 $1.03 | ▼ −0.96% | ▼ −0.00% | $1.11 (+6.25%) |
Sep 2, 2026 7w ago | 8-K | $1.04 $1.03 | ▼ −0.96% | ▼ −0.00% | $1.11 (+6.25%) |
Aug 15, 2026 10w ago | Institutional Cluster | $0.6394 $0.7209 | ▼ −12.75% | ▼ −13.94% | $1.11 (−72.82%) |
Aug 10, 2026 11w ago | 8-K | $0.6437 $0.6600 | ▼ −2.53% | ▼ −2.94% | $1.11 (−71.66%) |
Aug 10, 2026 11w ago | Press Release | $0.6437 $0.6600 | ▼ −2.53% | ▼ −2.94% | $1.11 (−71.66%) |
Jun 24, 2026 17w ago | 8-K | $0.6280 $0.7999 | ▼ −27.37% | ▼ −25.81% | $1.11 (−75.96%) |
Apr 23, 2026 26w ago | DEFA14A | $1.02 $0.9530 | ▼ −6.57% | ▼ −7.48% | $1.11 (+8.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers